Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)

Clinical trial NCT00839306 · COMPLETED

Trial details

NCT number: NCT00839306
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease (GERD)

Start date: 2008-08-01
Primary completion: 2009-08-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.